Share-based Payment Arrangement, Expense in USD of PROKIDNEY CORP. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PROKIDNEY CORP. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2020 to Q3 2025.
  • PROKIDNEY CORP. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $6.68M, a 3.74% decline year-over-year.
  • PROKIDNEY CORP. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $26.6M, a 65.6% increase year-over-year.
  • PROKIDNEY CORP. annual Share-based Payment Arrangement, Expense for 2024 was $29.4M, a 4.78% decline from 2023.
  • PROKIDNEY CORP. annual Share-based Payment Arrangement, Expense for 2023 was $30.8M, a 58.6% decline from 2022.
  • PROKIDNEY CORP. annual Share-based Payment Arrangement, Expense for 2022 was $74.5M, a 10554% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PROKIDNEY CORP. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $26.6M $6.68M -$259K -3.74% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $26.8M $6.54M -$1.27M -16.2% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $28.1M $6.42M -$1.26M -16.5% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025
Q4 2024 $29.4M $6.95M +$13.3M 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025
Q3 2024 $16.1M $6.93M -$6.06M -46.6% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 $22.1M $7.81M -$3.39M -30.3% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 $25.5M $7.68M -$5.34M -41% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025
Q4 2023 $30.8M -$6.37M -$15.3M -171% 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025
Q3 2023 $46.2M $13M +$8.15M +168% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $38M $11.2M +$3.2M +40% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024
Q1 2023 $34.8M $13M -$39.7M -75.3% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 $74.5M $8.94M 01 Oct 2022 31 Dec 2022 10-K 17 Mar 2025
Q3 2022 $4.84M +$4.84M 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $8M 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $52.7M 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q3 2021 $0 30 Sep 2021 10-Q 15 Nov 2021
Q3 2021 $175K 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022

PROKIDNEY CORP. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $29.4M -$1.47M -4.78% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025
2023 $30.8M -$43.6M -58.6% 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025
2022 $74.5M +$73.8M +10554% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025
2021 $699K -$31K -4.25% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2024
2020 $730K 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.